Perspective Therapeutics, Inc. Share Price
Equities
CATX
US46489V1044
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.4 USD | +6.06% | -6.67% | +248.26% |
Sales 2024 * | 523K 43.62M | Sales 2025 * | 321K 26.81M | Capitalization | 930M 77.6B |
---|---|---|---|---|---|
Net income 2024 * | -54M -4.5B | Net income 2025 * | -64M -5.34B | EV / Sales 2024 * | 1,779 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2,895 x |
P/E ratio 2024 * |
-14
x | P/E ratio 2025 * |
-12.7
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.46% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | +6.06% | ||
1 week | -6.67% | ||
Current month | +1.45% | ||
1 month | -19.08% | ||
3 months | +47.55% | ||
6 months | +438.46% | ||
Current year | +248.26% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 52 | 03/23/03 |
Mark Austin
DFI | Director of Finance/CFO | 37 | 01/17/01 |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 03/23/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 01/23/01 |
Lori Woods
CHM | Chairman | 61 | 03/23/03 |
Director/Board Member | 58 | 03/23/03 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 1.38 | +4.55% | 15,608,571 |
30/24/30 | 1.32 | -2.22% | 3,465,825 |
29/24/29 | 1.35 | -13.46% | 11,158,140 |
28/24/28 | 1.56 | +4.00% | 13,266,819 |
Delayed Quote Nyse, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+248.26% | 930M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- CATX Stock